Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly

Go back to Teladoc (TDOC) +2% on addition of GLP-1 self-pay option with Lilly

Truist Securities Reiterates Hold Rating on Teladoc (TDOC)

March 6, 2025 2:09 PM EST

Truist Securities analyst Jaliendra Singh reiterated a Hold rating and $10.00 price target on Teladoc (NYSE: TDOC)

The analyst comments "This morning, TDOC announced a pharmacy integration agreement with Gifthealth (private), a pharmacy partner for Eli Lilly's LillyDirect (LLY, Buy, Devarakonda). The partnership is expected to... More